// company-profile

Palisade Bio, Inc.

PALI
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings83Insiders14
// api This Palisade Bio, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 11 insiders purchased shares. Buying was led by Chuang Emil.

// 90-day insight

Over the last 90 days, Palisade Bio, Inc. insiders bought $0 across 11 transactions with no open-market sales.

  • Most active insider: Chuang Emil with 3 transactions totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Palisade Bio, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$255.0M
QoQ change
-18.0%
Reporting period
2026-03-31
#1
B Group, Inc.
CIK 2043476
$20.0M
11.4M shares
#2
JANUS HENDERSON GROUP PLC
CIK 1274173
$18.8M
10.7M shares
#3
Octagon Capital Advisors LP
CIK 1839435
$18.0M
10.3M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 10, 2026Chuang EmilPALI
Option Exercise
20,200
Jun 10, 2026Williams Donald AllenPALI
Award
1,498,900
Jun 10, 2026Williams Donald AllenPALI
Option Exercise
60,666
Jun 10, 2026Williams Donald AllenPALI
Option Exercise
60,666$0.00$0K
Jun 10, 2026Wei BinxianPALI
Award
592,300

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.